Characteristics of patients and exacerbations in the ongoing Asthma: Phenotyping Exacerbations (APEX) studies.
A. Pradhan (Nottingham, United Kingdom), R. Needham (Nottingham, United Kingdom), K. Shaw (Nottingham, United Kingdom), M. Martin (Nottingham, United Kingdom), M. Portelli (Nottingham, United Kingdom), I. Sayers (Nottingham, United Kingdom), T. Harrison (Nottingham, United Kingdom)
Source: International Congress 2022 – Alpha-1 antitrypsin deficiency and chronic airway obstructive diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Pradhan (Nottingham, United Kingdom), R. Needham (Nottingham, United Kingdom), K. Shaw (Nottingham, United Kingdom), M. Martin (Nottingham, United Kingdom), M. Portelli (Nottingham, United Kingdom), I. Sayers (Nottingham, United Kingdom), T. Harrison (Nottingham, United Kingdom). Characteristics of patients and exacerbations in the ongoing Asthma: Phenotyping Exacerbations (APEX) studies.. 2438
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|